Probiotics.

Area of Science:

• Microbiology
• Gastroenterology
• Pharmacology

Background:

• Probiotics are live nonpathogenic microorganisms, including yeast (Saccharomyces boulardii) and bacteria (Lactobacillus, Bifidobacterium species).
• They are regulated as dietary supplements and foods, aiming to enhance microbial balance, especially in the gastrointestinal tract.
• Probiotics function by lowering intestinal pH, inhibiting pathogen colonization, and modulating the host immune response.

Purpose of the Study:

• To review the pharmacology, uses, dosages, safety, drug interactions, and contraindications of probiotics.
• To summarize the current evidence for probiotic efficacy in various health conditions.
• To provide guidance on the appropriate use of probiotics.

Main Methods:

• Literature review of existing studies on probiotics.
• Analysis of mechanisms of action and clinical applications.
• Evaluation of safety profiles and drug interactions.

Main Results:

• Probiotics demonstrate the strongest evidence for treating acute diarrhea (e.g., rotavirus-induced) and pouchitis.
• Further research is necessary to establish the role of probiotics in preventing antibiotic-associated diarrhea, Clostridium difficile infection, and managing conditions like IBS and IBD.
• Probiotics are generally safe, with common side effects including bloating and flatulence; caution is recommended for critically ill or immunocompromised patients.

Conclusions:

• Probiotics have proven efficacy in preventing and treating specific medical conditions, primarily gastrointestinal ones.
• The benefits of probiotics are strain-specific, and not all strains offer the same therapeutic effects.
• While generally safe, potential risks exist for vulnerable populations, and optimal dosing remains under investigation.